Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer

Journal of Clinical Oncology

Volumn 33, Issue 13, 2015, Pages 1453-1459

  Nightingale, Ginah ^a   Hajjar, Emily ^a   Swartz, Kristine ^b   Andrel Sendecki, Jocelyn ^a   Chapman, Andrew ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER THERAPY; COMORBIDITY; FEMALE; HEALTH CARE QUALITY; HEMATOLOGIC MALIGNANCY; HUMAN; INAPPROPRIATE PRESCRIBING; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; METASTASIS; NEOPLASM; PHARMACIST; POLYPHARMACY; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; RETROSPECTIVE STUDY; SELF REPORT; SOLID TUMOR; AGE; EVALUATION STUDY; MEDICATION THERAPY MANAGEMENT; MIDDLE AGED; NEOPLASMS; PENNSYLVANIA; PRESCRIPTION; PREVENTION AND CONTROL; PROGRAM EVALUATION; RISK FACTOR; VERY ELDERLY;

ANTINEOPLASTIC AGENT;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; COMORBIDITY; DRUG PRESCRIPTIONS; FEMALE; HUMANS; INAPPROPRIATE PRESCRIBING; MALE; MEDICATION RECONCILIATION; MIDDLE AGED; NEOPLASMS; PHARMACISTS; PHILADELPHIA; POLYPHARMACY; PROGRAM EVALUATION; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84929453987     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.58.7550     Document Type: Article

References (33)

1. Smith BD, Smith GL, Hurria A, et al: Future of cancer incidence in the United States: Burdens upon an aging, changing nation. J Clin Oncol 27:2758-2765, 2009
2. Vira T, Colquhoun M, Etchells E: Reconcilable differences: Correcting medication errors at hospital admission and discharge. Qual Saf Health Care 15:122-126, 2006
3. Coleman EA, Smith JD, Raha D, et al: Posthospital medication discrepancies: Prevalence and contributing factors. Arch Intern Med 165:1842-1847, 2005
4. Riechelmann RP, Tannock IF, Wang L, et al: Potential drug interactions and duplicate prescriptions among cancer patients. J Natl Cancer Inst 99:592-600, 2007
5. Riechelmann RP, Zimmermann C, Chin SN, et al: Potential drug interactions in cancer patients receiving supportive care exclusively. J Pain Symptom Manage 35:535-543, 2008
6. Riechelmann RP, Moreira F, Smaletz O, et al: Potential for drug interactions in hospitalized cancer patients. Cancer Chemother Pharmacol 56:286-290, 2005
7. Puts MT, Costa-Lima B, Monette J, et al: Medication problems in older, newly diagnosed cancer patients in Canada: How common are they? A prospective pilot study. Drugs Aging 26:519-536, 2009
8. Scripture CD, Figg WD: Drug interactions in cancer therapy. Nat Rev Cancer 6:546-558, 2006
9. Extermann M, Hurria A: Comprehensive geriatric assessment for older patients with cancer. J Clin Oncol 25:1824-1831, 2007
10. National Comprehensive Cancer Network: The NCCN Clinical Practice Guidelines in Oncology, Older Adult Oncology (version 2015). www.NCCN.org
11. Lichtman SM, Boparai MK. Geriatric medication management: Evaluation of pharmacist interventions and potentially inappropriate medication (PIM) use in older (> 65 years) cancer patients. J Clin Oncol 27:484s, 2009 (suppl; abstr 9507)
12. Maggiore RJ, Gross CP, Hardt M, et al: Polypharmacy, potentially inappropriate medications, and chemotherapy-related adverse events among older adults with cancer. J Clin Oncol 29, 2011 (suppl; abstr e19501)
13. Prithviraj GK, Koroukian S, Margevicius S, et al: Patient characteristics associated with polypharmacy and inappropriate prescribing of medications among older adults with cancer. J Geriatr Oncol 3:228-237, 2012
14. Maggiore RJ, Feng T, Dale W, et al: Measures of polypharmacy and chemotherapy toxicity in older adults with cancer. J Clin Oncol 31, 2013 (suppl 15s; abstr 9545)
15. Stewart RB: Polypharmacy in the elderly: A fait accompli? DICP 24:321-323, 1990
16. Montamat SC, Cusack B: Overcoming problems with polypharmacy and drug misuse in the elderly. Clin Geriatr Med 8:143-158, 1992
17. Hajjar ER, Cafiero AC, Hanlon JT: Polypharmacy in elderly patients. Am J Geriatr Pharmacother 5:345-351, 2007
18. Hovstadius B, Petersson G: Factors leading to excessive polypharmacy. Clin Geriatr Med 28:159-172, 2012
19. Gallagher P, O'Mahony D: STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions): Application to acutely ill elderly patients and comparison with Beers' criteria. Age Ageing 37:673-679, 2008
20. O'Mahony D, Gallagher P, Ryan C, et al: STOPP & START criteria: A new approach to detecting potentially inappropriate prescribing in old age. Eur Geriatr Med 1:45-51, 2010
21. Hamilton H, Gallagher P, Ryan C, et al: Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med 171:1013-1019, 2011
22. National Committee on Quality Assurance: Drugs to be avoided in the elderly. December 11, 2011
23. American Geriatrics Society 2012 Beers Criteria Update Expert Panel: American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 60:616-631, 2012
24. Oken MM, Creech RH, Tormey DC, et al: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649-655, 1982
25. Balducci L, Extermann M: Management of cancer in the older person: A practical approach. Oncologist 5:224-237, 2000
26. Sokol KC, Knudsen JF, Li MM: Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect management. J Clin Pharm Ther 32:169-175, 2007
27. Walker PC, Bernstein SJ, Jones JN, et al: Impact of a pharmacist-facilitated hospital discharge program: A quasi-experimental study. Arch Intern Med 169:2003-2010, 2009
28. Schnipper JL, Kirwin JL, Cotugno MC, et al: Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med 166:565-571, 2006
29. Thompson CA: High-risk patients benefit from clinical pharmacy services collaborative. Am J Health Syst Pharm 68:465, 2011
30. Setter SM, Corbett CF, Neumiller JJ, et al: Effectiveness of a pharmacist-nurse intervention on resolving medication discrepancies for patients transitioning from hospital to home health care. Am J Health Syst Pharm 66:2027-2031, 2009
31. Murphy EM, Oxencis CJ, Klauck JA, et al: Medication reconciliation at an academic medical center: Implementation of a comprehensive program from admission to discharge. Am J Health Syst Pharm 66:2126-2131, 2009
32. Ponniah A, Anderson B, Shakib S, et al: Pharmacists' role in the post-discharge management of patients with heart failure: A literature review. J Clin Pharm Ther 32:343-352, 2007
33. Ellitt GR, Brien JE, Aslani P, et al: Quality patient care and pharmacists' role in its continuity: A systematic review. Ann Pharmacother 43:677-691, 2009